Multicenter Evaluation of the Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa to Ceftolozane/Tazobactam Combination
Clinical trial NCT03963297 · COMPLETED
Trial details
- NCT number
- NCT03963297
- Sponsor
- Fondation Hôpital Saint-Joseph
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-03-01
- Primary completion
- 2020-03-01
- Enrollment
- 747
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.